-
BioVie's Lead Drug Candidate Aims To Treat Neurodegenerative Disease By Targeting Inflammation
Tuesday, September 19, 2023 - 8:45am | 747As researchers continue to hunt for better treatments for neurodegenerative disease, one of the biggest breakthroughs in decades has been the realization that chronic inflammation may be playing a key role in the onset and progression of debilitating diseases like Alzheimer’s and Parkinson...
-
Three Biotech Companies With Large Upside Potential
Thursday, October 6, 2016 - 1:25pm | 1284Here's a look at three small-cap biotech stocks looking to capitalize on their novel technologies and solid management: Posted by the MicroCap mavens at SecretCaps! Sophiris Bio Inc (NASDAQ: SPHS) Sophiris’s lead drug, PRX302 (topsalysin), is being evaluated for the treatment...